{"id":"8df35ddc-90ef-48d7-abd1-9e6f462df3d2","kind":"companies","code":"UB-C4457","name":"MEDvidi","nameBasis":"source-english","summary":"Online mental health consultation, diagnosis and treatment platform.","description":"Online mental health platform providing virtual psychiatric consultations, therapy, and prescription management.","country":"United States","category":null,"originalName":"MEDvidi","eventDate":null,"website":"https://medvidi.com/","sourceUpdatedAt":"2026-10-05T00:00:00.000Z","englishUpdatedAt":"2026-10-15T20:12:54.310Z","reviewedAt":"2026-10-15T20:12:54.310Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a9a4e36f32bbb856277e3c86dc963f52dec2f9a721fb854af03a7a683f74b462","companyId":null,"foundedYear":2019,"logoUrl":null,"originalText":"在线精神健康咨询诊疗平台\n\nOnline mental health platform providing virtual psychiatric consultations, therapy, and prescription management.","sources":[],"related":[{"id":"2ec6406c-2568-44d4-bc08-8bb65a892913","kind":"news","code":"2ec6406c-2568-44d4-bc08-8bb65a892913","name":"MEDvidi reaches USD 20 million in ARR","nameBasis":"translated-title","summary":"On 2025/9/26, LinkedIn reported that MEDvidi, a US telehealth platform, reached USD 20 million in annual recurring revenue and became profitable in 2025. It did not disclose its funding round, investors, or valuation.","description":"","country":null,"category":null,"originalName":"MEDvidi ARR达到2000万美元","eventDate":"2025-09-26T00:00:00.000Z","website":"https://www.linkedin.com/posts/alex-kulitski_in-2025-medvidi-became-profitable-we-activity-7376980066573905920-xQgd","sourceUpdatedAt":"2026-10-10T19:04:20.817Z","englishUpdatedAt":"2026-10-15T22:45:51.374Z","reviewedAt":"2026-10-15T22:45:51.374Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0a0a54060e50b6b8ea111c7f7268797aba5a5186cd91558929920c82c3e65c4f","companyId":"8df35ddc-90ef-48d7-abd1-9e6f462df3d2","foundedYear":null,"logoUrl":null,"path":"/news/2ec6406c-2568-44d4-bc08-8bb65a892913"},{"id":"98610e31-a718-4509-903a-d3fcefc69a4e","kind":"news","code":"98610e31-a718-4509-903a-d3fcefc69a4e","name":"MEDvidi reaches USD 22 million ARR","nameBasis":"translated-title","summary":"On 2025/10/17, LinkedIn reported that US telemedicine platform MEDvidi had grown annual recurring revenue from USD 17 million to USD 22 million within one quarter. It did not disclose its funding round, investors or valuation.","description":"","country":null,"category":null,"originalName":"MEDvidi ARR达到2200万美元","eventDate":"2025-10-17T00:00:00.000Z","website":"https://www.linkedin.com/posts/alex-kulitski_from-17m-to-22m-arr-in-just-one-quarter-activity-7384211332180365312-Ti9U","sourceUpdatedAt":"2026-10-10T19:04:19.826Z","englishUpdatedAt":"2026-10-15T23:42:44.022Z","reviewedAt":"2026-10-15T23:42:44.022Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5cb237814268a4955a5ce5a73f2ee903b15134a3e0f940a6781bfb955c8c934f","companyId":"8df35ddc-90ef-48d7-abd1-9e6f462df3d2","foundedYear":null,"logoUrl":null,"path":"/news/98610e31-a718-4509-903a-d3fcefc69a4e"},{"id":"a8ad8464-77eb-4bd8-b8ca-e5389d6d2d94","kind":"news","code":"a8ad8464-77eb-4bd8-b8ca-e5389d6d2d94","name":"MEDvidi reaches USD 25 million ARR","nameBasis":"translated-title","summary":"On 2025/11/24, LinkedIn reported that US telemedicine platform MEDvidi had reached USD 25 million in annual recurring revenue, having just achieved its fastest monthly growth. It did not disclose funding or valuation.","description":"","country":null,"category":null,"originalName":"MEDvidi ARR达到2500万美元","eventDate":"2025-11-24T00:00:00.000Z","website":"https://www.linkedin.com/posts/alex-kulitski_medvidi-just-had-the-fastest-growing-month-activity-7398738227039465472-nK3U","sourceUpdatedAt":"2026-10-08T05:28:02.127Z","englishUpdatedAt":"2026-10-15T23:49:37.344Z","reviewedAt":"2026-10-15T23:49:37.344Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"800ed20305a67c11f3ab97d04843319ad89e8369813f4bdd5a8f4dc956e05cdb","companyId":"8df35ddc-90ef-48d7-abd1-9e6f462df3d2","foundedYear":null,"logoUrl":null,"path":"/news/a8ad8464-77eb-4bd8-b8ca-e5389d6d2d94"}],"events":[{"id":"a8ad8464-77eb-4bd8-b8ca-e5389d6d2d94","kind":"other","eventDate":"2025-11-24T00:00:00.000Z","revenueDate":"2025-11-24T00:00:00.000Z","round":null,"amountText":null,"valuationText":null,"revenueText":"2500万美元（ARR）","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":25000000,"cumulativeFundingEstimateUsd":null,"investors":null,"newsUrl":"https://www.linkedin.com/posts/alex-kulitski_medvidi-just-had-the-fastest-growing-month-activity-7398738227039465472-nK3U","newsTypes":["收入"],"institutions":[]},{"id":"98610e31-a718-4509-903a-d3fcefc69a4e","kind":"other","eventDate":"2025-10-17T00:00:00.000Z","revenueDate":"2025-10-17T00:00:00.000Z","round":null,"amountText":null,"valuationText":null,"revenueText":"2200万美元（ARR）","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":22000000,"cumulativeFundingEstimateUsd":null,"investors":null,"newsUrl":"https://www.linkedin.com/posts/alex-kulitski_from-17m-to-22m-arr-in-just-one-quarter-activity-7384211332180365312-Ti9U","newsTypes":["收入"],"institutions":[]},{"id":"2ec6406c-2568-44d4-bc08-8bb65a892913","kind":"other","eventDate":"2025-09-26T00:00:00.000Z","revenueDate":"2025-09-26T00:00:00.000Z","round":null,"amountText":null,"valuationText":null,"revenueText":"2000万美元（ARR）","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":20000000,"cumulativeFundingEstimateUsd":null,"investors":null,"newsUrl":"https://www.linkedin.com/posts/alex-kulitski_in-2025-medvidi-became-profitable-we-activity-7376980066573905920-xQgd","newsTypes":["收入"],"institutions":[]}],"finance":{"funding":{"metric":"funding","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]},"valuation":{"metric":"valuation","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]},"revenue":{"metric":"revenue","count":3,"latest":{"value":25000000,"text":"2500万美元（ARR）","date":"2025-11-24T00:00:00.000Z","round":null,"estimate":"$25M"},"years":[2025],"points":[{"year":2025,"date":"2025-09-26T00:00:00.000Z","round":null,"value":20000000,"eventIds":["2ec6406c-2568-44d4-bc08-8bb65a892913"]},{"year":2025,"date":"2025-10-17T00:00:00.000Z","round":null,"value":22000000,"eventIds":["98610e31-a718-4509-903a-d3fcefc69a4e"]},{"year":2025,"date":"2025-11-24T00:00:00.000Z","round":null,"value":25000000,"eventIds":["a8ad8464-77eb-4bd8-b8ca-e5389d6d2d94"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"a8ad8464-77eb-4bd8-b8ca-e5389d6d2d94","date":"2025-11-24T00:00:00.000Z","round":null,"amountText":"2500万美元（ARR）","estimateUsd":25000000,"estimateLabel":"$25M","investors":null,"institutions":[],"newsUrl":"https://www.linkedin.com/posts/alex-kulitski_medvidi-just-had-the-fastest-growing-month-activity-7398738227039465472-nK3U"},{"id":"98610e31-a718-4509-903a-d3fcefc69a4e","date":"2025-10-17T00:00:00.000Z","round":null,"amountText":"2200万美元（ARR）","estimateUsd":22000000,"estimateLabel":"$22M","investors":null,"institutions":[],"newsUrl":"https://www.linkedin.com/posts/alex-kulitski_from-17m-to-22m-arr-in-just-one-quarter-activity-7384211332180365312-Ti9U"},{"id":"2ec6406c-2568-44d4-bc08-8bb65a892913","date":"2025-09-26T00:00:00.000Z","round":null,"amountText":"2000万美元（ARR）","estimateUsd":20000000,"estimateLabel":"$20M","investors":null,"institutions":[],"newsUrl":"https://www.linkedin.com/posts/alex-kulitski_in-2025-medvidi-became-profitable-we-activity-7376980066573905920-xQgd"}]}},"team":[],"productsRelated":[],"investors":[],"path":"/companies/medvidi","canonical":"https://uniquebase.ai/companies/medvidi"}